RISE Life Science Corp. to Acquire California CBD Company Life Bloom Organics and Leading Cannabis Brand Strategy Agency Cultivate Kind Cannabis Investing News
Q BioMed Inc. Provides Important Update on Mannin Research Tie2 Technology Platform Development Biotech Investing
Axovant Licenses Investigational Gene Therapy for Parkinson’s Disease from Oxford BioMedica and Announces Key Leadership Team Addition Biotech Investing
argenx receives feedback from FDA in end-of-phase 2 meeting for efgartigimod in myasthenia gravis Biotech Investing
Verastem Oncology and Yakult Honsha Sign Exclusive License Agreement for the Development and Commercialization of Duvelisib in Japan Pharmaceutical Investing
TESARO Announces Collaboration to Evaluate ZEJULA in Combination With Anti-PD-L1 Cancer Immunotherapy and MEK Inhibitor in Platinum-Sensitive Ovarian Cancer Pharmaceutical Investing
Summit Therapeutics Reports Financial Results for the First Quarter Ended 30 April 2018 and Operational Progress Pharmaceutical Investing
Protalix BioTherapeutics Announces Additional Positive Results from Final Analysis of the Phase II Clinical Trial of OPRX-106 for the Treatment of Ulcerative Colitis Biotech Investing
